Literature DB >> 18442887

Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator.

Hiroyuki Tamiya1, Toshiyuki Ikeda, Jae-Hwan Jeong, Taku Saito, Fumiko Yano, Youn-Kwan Jung, Shinsuke Ohba, Hiroshi Kawaguchi, Ung-Il Chung, Je-Yong Choi.   

Abstract

Little is known about the upstream regulator of Runx2, a master regulator of osteoblast differentiation in bone tissues. To elucidate the molecular mechanism of Runx2 gene expression, we analyzed Runx2 promoter activity in osseous (MC3T3-E1, KS483, Kusa) and non-osseous (NIH3T3, C3H10T1/2, mouse embryonic fibroblasts) cells and also identified Runx2 upstream regulator using a Runx2 promoter-derived luciferase reporter system. After cloning 15 serial deletion constructs from -6832 bp/+390 bp to -37 bp/+390 bp of the Runx2-P1 promoter, we performed a transient transfection assay in osseous and non-osseous cells. A reduction in Runx2 promoter activity was observed in two regions; one was between -3 kb and -1 kb, and the other was between -155 bp and -75 bp. The step-down pattern in promoter activity between -3 kb and -1 kb was observed only in osseous cells. Interestingly, the step-down pattern between -155 bp and -75 bp was revealed in both cell types. Consistently, beta-galactosidase staining in axial skeleton of -3 kb-Runx2-P1-LacZ transgenic mice was positive, but that of all skeletal tissues of -1 kb-Runx2-P1-LacZ transgenic mice was negative. To identify upstream regulators of the Runx2-P1 promoter, we screened 100 transcription factors using Runx2-P1-luciferase reporter constructs in NIH3T3 fibroblasts and HeLa cells. Among them, HIF2A was identified as the strongest activator of Runx2-P1 promoter activity. A HIF2A-responsive site on the Runx2 promoter was identified between -106 bp and -104 bp by mutation analysis. An electrophoretic mobility shift assay and chromatin immunoprecipitation assay confirmed the binding of HIF2A to the Runx2-P1 promoter in vitro and in vivo, respectively. Knock-down using siRNA against HIF2A confirmed that HIF2A is an important regulator of Runx2 gene expression. Collectively, these results suggest that the region between -3 kb and -1 kb is required for the minimal skeletal tissue-specific expression of Runx2, and that the region between -155 bp and -75 bp is important for its basal transcription, which may be in part mediated by HIF2A in bone tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18442887     DOI: 10.1016/j.gene.2008.03.003

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  24 in total

1.  Dose-dependent effects of Runx2 on bone development.

Authors:  Shiqin Zhang; Zhousheng Xiao; Junming Luo; Nan He; Josh Mahlios; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

2.  Genomic occupancy of HLH, AP1 and Runx2 motifs within a nuclease sensitive site of the Runx2 gene.

Authors:  Hayk Hovhannisyan; Ying Zhang; Mohammad Q Hassan; Hai Wu; Carlotta Glackin; Jane B Lian; Janet L Stein; Martin Montecino; Gary S Stein; Andre J van Wijnen
Journal:  J Cell Physiol       Date:  2013-02       Impact factor: 6.384

Review 3.  HMGB proteins and arthritis.

Authors:  Noboru Taniguchi; Yasuhiko Kawakami; Ikuro Maruyama; Martin Lotz
Journal:  Hum Cell       Date:  2017-09-15       Impact factor: 4.174

4.  Epigenetic regulation of Runx2 transcription and osteoblast differentiation by nicotinamide phosphoribosyltransferase.

Authors:  Min Ling; Peixin Huang; Shamima Islam; Daniel P Heruth; Xuanan Li; Li Qin Zhang; Ding-You Li; Zhaohui Hu; Shui Qing Ye
Journal:  Cell Biosci       Date:  2017-05-23       Impact factor: 7.133

5.  Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition.

Authors:  Kenichi Tamama; Haruhisa Kawasaki; Svetoslava S Kerpedjieva; Jianjun Guan; Ramesh K Ganju; Chandan K Sen
Journal:  J Cell Biochem       Date:  2011-03       Impact factor: 4.429

6.  Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development.

Authors:  Taku Saito; Atsushi Fukai; Akihiko Mabuchi; Toshiyuki Ikeda; Fumiko Yano; Shinsuke Ohba; Nao Nishida; Toru Akune; Noriko Yoshimura; Takumi Nakagawa; Kozo Nakamura; Katsushi Tokunaga; Ung-Il Chung; Hiroshi Kawaguchi
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

7.  Expression patterns and function of chromatin protein HMGB2 during mesenchymal stem cell differentiation.

Authors:  Noboru Taniguchi; Beatriz Caramés; Emily Hsu; Stephanie Cherqui; Yasuhiko Kawakami; Martin Lotz
Journal:  J Biol Chem       Date:  2011-09-02       Impact factor: 5.157

8.  Increased Runx2 expression associated with enhanced Wnt signaling in PDLLA internal fixation for fracture treatment.

Authors:  Zhuoyan Ling; Lei Wu; Gaolong Shi; Li Chen; Qirong Dong
Journal:  Exp Ther Med       Date:  2017-03-10       Impact factor: 2.447

9.  New findings in osteoarthritis pathogenesis: therapeutic implications.

Authors:  Lia Pulsatelli; Olga Addimanda; Veronica Brusi; Branka Pavloska; Riccardo Meliconi
Journal:  Ther Adv Chronic Dis       Date:  2013-01       Impact factor: 5.091

Review 10.  Role of hypoxia-inducible factor-1alpha in angiogenic-osteogenic coupling.

Authors:  Ryan C Riddle; Richa Khatri; Ernestina Schipani; Thomas L Clemens
Journal:  J Mol Med (Berl)       Date:  2009-05-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.